<MedlineCitation Status="Completed">
<MedlineID>10011782</MedlineID>
<PMID>421090</PMID>
<DateCreated>
<Year>1979</Year>
<Month>05</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>05</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0007-1447</ISSN>
<JournalIssue>
<Volume>1</Volume>
<Issue>6159</Issue>
<PubDate>
<Year>1979</Year>
<Month>Feb</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>Rifampicin-induced non-responsiveness to corticosteroid treatment in nephrotic syndrome.</ArticleTitle>
<Pagination>
<MedlinePgn>306</MedlinePgn>
</Pagination>
<AuthorList>
<Author>
<LastName>Hendrickse</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author>
<LastName>McKiernan</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author>
<LastName>Pickup</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author>
<LastName>Lowe</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>ENGLAND</Country>
<MedlineTA>Br Med J</MedlineTA>
<NlmUniqueID>0372673</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>13292-46-1</RegistryNumber>
<NameOfSubstance>Rifampin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-24-8</RegistryNumber>
<NameOfSubstance>Prednisolone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName>Case Report</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Drug Interactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Human</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Nephrotic Syndrome</DescriptorName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Prednisolone</DescriptorName>
<QualifierName>antagonists &#38; inhibitors</QualifierName>
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Rifampin</DescriptorName>
<QualifierName MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
